Multiple sclerosis (MS) and functional neurological disorders (FND) share clinical features, which may result in FND being overlooked in patients with MS. They also share common comorbidities, including depression and alexithymia.
As their management differs, assessing the frequency and determinants of FND in patients with MS is important to improve diagnosis and ensure appropriate management.
Adult patient (≥ 18 years of age)
Diagnosis of multiple sclerosis (MS) according to the 2024 McDonald criteria
Stable brain MRI performed within the previous 12 months
No relapse between the MRI and study enrollment
Patient unwilling to participate in the study
Known severe psychotic disorder
Patient under judicial protection (sauvegarde de justice)
Patient under guardianship or curatorship (tutelle or curatelle)
During a routine medical visit, eligible patients will be informed about the study and invited to participate. The two participating centers, located in Strasbourg and Nancy, each have an active cohort allowing the required number of participants to be recruited within one year.
Case-only
Prospective
Not listed
Assessment of the frequency of TNF in patients with multiple sclerosis
Assessment of the frequency of TNF in patients with multiple sclerosis
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
